Shopping Cart 0
Cart Subtotal
AED 0

Global Weight Loss and Obesity Management Market (By Drug Type- Peripherally Acting Drugs and Centrally Acting Drugs. By Distribution Channel- Hypermarkets/ Supermarkets, Pharmaceutical Stores and Online Market. By Type- Over-The-Counter Drugs and Prescription Drugs. By Duration of Therapy- Short-Term Drugs and Long-Term Drugs) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2017 - 2025

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 17598

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 24938

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 28608

Details

The report covers the analysis and forecast of the Weight loss or obesity medications market on global as well as regional level. The study provides historic data of 2016 along with the forecast for the period between 2017 and 2025 based on revenue (USD Mn).

The study provides a detailed view of the weight loss or obesity medications market, by segmenting it based on by drugs type, by distribution channel, by type, by duration of therapy and regional demand. Rising concern in people regarding health problems due to obesity and over-weight, creates a huge demand for weight loss or obesity medicines. Growing incidences of lifestyle related diseases is also a prime factor augmenting the growth of weight loss or obesity medications market during the forecast period.

Regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Middle East and Africa and Latin America. The segmentation also includes by drug type, by distribution channel, by type and duration of therapy.

A comprehensive analysis of the market dynamics that is inclusive of market drivers, restraints, and opportunities is part of the report. Additionally, the report includes potential opportunities in the weight loss or obesity medications market at the global and regional levels. Market dynamics are the factors which impact the market growth, so their analysis helps understand the ongoing trends of the global market. Therefore, the report provides the forecast of the global market for the period from 2017 to 2025, along with offering an inclusive study of the Weight loss or obesity medications market.

The report provides the size of the Weight loss or obesity medications market in 2016 and the forecast for the next nine years up to 2025. The size of the global weight loss or obesity medications market is provided in terms of revenue. Market revenue is defined in USD Mn. The market dynamics prevalent in North America, Europe, Asia Pacific, Middle East and Africa and Latin America has been taken into account in estimating the growth of the global market.

Market estimates for this study have been based on revenue being derived through regional pricing trends. The weight loss or obesity medications market has been analyzed based on expected demand. We have used the bottom-up approach to estimate the global revenue of the weight loss or obesity medications market, split into regions. Based on, drug type, distribution channel, type and duration of therapy we have summed up the individual revenues from all the regions to achieve the global revenue for weight loss or obesity medications. Companies were considered for the market share analysis, based on their innovation and application and revenue generation. In the absence of specific data related to the sales of weight loss or obesity medications several privately held companies, calculated assumptions have been made in view of the company's penetration and regional presence.

The report covers a detailed competitive outlook that includes the market share and company profiles of key players operating in the global market. Key players profiled in the report include Orexigen Therapeutics Inc., Norgine B.V., Amway Enterprises, Merck & Co. Inc., Pfizer Inc., and few likely to be named.

The global weight loss or obesity medications market has been segmented into:

Global Weight Loss or Obesity Medications Market: By Drug Type

Peripherally Acting Drugs

Centrally Acting Drugs

Global Weight Loss or Obesity Medications Market: By Distribution Channel

Hypermarket/ Supermarket

Pharmaceutical Stores

Online Market

Global Weight Loss or Obesity Medications Market: By Type

Over-The-Counter Drugs

Prescription Drugs

Global Weight Loss or Obesity Medications Market: By Duration of Therapy

Short-Term Drugs

Long-Term Drugs

Global Weight Loss or Obesity Medications Market: By Geography

North America

o U.S.

o Canada

o Mexico

Europe

o U.K.

o France

o Germany

o Italy

o Rest of Europe

Asia Pacific

o India

o China

o Japan

o Rest of Asia Pacific

Middle East and Africa

o South Africa

o Rest of Middle East and Africa

Latin America

o Brazil

o Rest of Latin America

READ MORE

Table Of Content

Scope

1 INTRODUCTION

1.1 MARKET SEGMENTATION

2 RESEARCH METHODOLOGY

2.1 ECOSYSTEM OF WEIGHT LOSS AND OBESITY MANAGEMENT MARKET

2.2 TOP-DOWN APPROACH

2.3 BOTTOM-UP APPROACH

2.4 ASSUMPTIONS

3 EXECUTIVE SUMMARY

3.1 GLOBAL WEIGHT LOSS AND OBESITY MANAGEMENT MARKET SNAPSHOT

3.2 GLOBAL WEIGHT LOSS AND OBESITY MANAGEMENT MARKET REVENUE, 2017- 2025(USD MN)

4 MARKET OVERVIEW

4.1 INTRODUCTION

4.2 KEY TRENDS ANALYSIS

4.3 PRODUCT DEVELOPMENT AND DIVERSIFICATION ANALYSIS

4.4 PORTERS FIVE FORCE ANALYSIS

4.5 VALUE CHAIN ANALYSIS

4.6 COMPETITIVE LANDSCAPE

4.7 COMPANY MARKET SHARE ANALYSIS

4.8 EXPANSION STRATEGIES ADOPTED BY LEADING PLAYERS

5 GLOBAL WEIGHT LOSS AND OBESITY MANAGEMENT MARKET, BY DRUGS TYPE

5.1 OVERVIEW

5.2 PERIPHERALLY ACTING DRUGS

5.3 CENTRALLY ACTING DRUGS

6 GLOBAL WEIGHT LOSS AND OBESITY MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL

6.1 OVERVIEW

6.2 HYPERMARKET/ SUPERMARKET

6.3 PHARMACEUTICAL STORES

6.4 ONLINE MARKET

7 GLOBAL WEIGHT LOSS AND OBESITY MANAGEMENT MARKET, BY TYPE

7.1 OVERVIEW

7.2 OVER-THE-COUNTER DRUGS

7.3 PRESCRIPTION DRUGS

8 GLOBAL WEIGHT LOSS AND OBESITY MANAGEMENT MARKET, BY DURATION OF THERAPY

8.1 OVERVIEW

8.2 SHORT-TERM DRUGS

8.3 LONG-TERM DRUGS

9 GLOBAL WEIGHT LOSS AND OBESITY MANAGEMENT MARKET, BY GEOGRAPHY

9.1 NORTH AMERICA

9.1.1 MARKET DYNAMICS

9.1.1.1 DRIVERS

9.1.1.2 RESTRAINS

9.1.1.3 OPPORTUNITY

9.1.2 U.S.

9.1.3 CANADA

9.1.4 MEXICO

9.2 EUROPE

9.2.1 MARKET DYNAMICS

9.2.1.1 DRIVERS

9.2.1.2 RESTRAINS

9.2.1.3 OPPORTUNITY

9.2.2 U.K.

9.2.3 FRANCE

9.2.4 GERMANY

9.2.5 SPAIN

9.2.6 REST OF EUROPE

9.3 ASIA PACIFIC

9.3.1 MARKET DYNAMICS

9.3.1.1 DRIVERS

9.3.1.2 RESTRAINS

9.3.1.3 OPPORTUNITY

9.3.2 INDIA

9.3.3 CHINA

9.3.4 JAPAN

9.3.5 REST OF ASIA PACIFIC

9.4 MIDDLE EAST AND AFRICA

9.4.1 MARKET DYNAMICS

9.4.1.1 DRIVERS

9.4.1.2 RESTRAINS

9.4.1.3 OPPORTUNITY

9.4.2 SOUTH AFRICA

9.4.3 REST OF MIDDLE EAST AND AFRICA

9.5 LATIN AMERICA

9.5.1 MARKET DYNAMICS

9.5.1.1 DRIVERS

9.5.1.2 RESTRAINS

9.5.1.3 OPPORTUNITY

9.5.2 BRAZIL

9.5.3 REST OF LATIN AMERICA

10 COMPETATIVE LANDSCAPE

10.1 OVERVIEW

10.2 NEW PRODUCT LAUNCHES

11 GLOBAL WEIGHT LOSS AND OBESITY MANAGEMENT MARKET, BY COMPANY

11.1 INTRODUCTION

11.2 OREXIGEN THERAPEUTICS INC.

11.2.1 BUSINESS OVERVIEW

11.2.2 PRODUCTS & SERVICES

11.2.3 KEY STRATEGY

11.2.4 RECENT DEVELOPMENTS

11.2.5 SWOT ANALYSIS

11.3 AMWAY ENTERPRISES

11.3.1 BUSINESS OVERVIEW

11.3.2 PRODUCTS & SERVICES

11.3.3 KEY STRATEGY

11.3.4 RECENT DEVELOPMENTS

11.3.5 SWOT ANALYSIS

11.4 NORGINE B.V.

11.4.1 BUSINESS OVERVIEW

11.4.2 PRODUCTS & SERVICES

11.4.3 KEY STRATEGY

11.4.4 RECENT DEVELOPMENTS

11.4.5 SWOT ANALYSIS

11.5 MERCK & CO. INC.

11.5.1 BUSINESS OVERVIEW

11.5.2 PRODUCTS & SERVICES

11.5.3 KEY STRATEGY

11.5.4 RECENT DEVELOPMENTS

11.5.5 SWOT ANALYSIS

11.6 PFIZER INC.

11.6.1 BUSINESS OVERVIEW

11.6.2 PRODUCTS & SERVICES

11.6.3 KEY STRATEGY

11.6.4 RECENT DEVELOPMENTS

11.6.5 SWOT ANALYSIS

11.7 ARENA PHARMACEUTICALS INC.

11.7.1 BUSINESS OVERVIEW

11.7.2 PRODUCTS & SERVICES

11.7.3 KEY STRATEGY

11.7.4 RECENT DEVELOPMENTS

11.7.5 SWOT ANALYSIS

11.8 GLAXOSMITHKLINE LIMITED

11.8.1 BUSINESS OVERVIEW

11.8.2 PRODUCTS & SERVICES

11.8.3 KEY STRATEGY

11.8.4 RECENT DEVELOPMENTS

11.8.5 SWOT ANALYSIS

11.9 NOVO NORDISK A/S

11.9.1 BUSINESS OVERVIEW

11.9.2 PRODUCTS & SERVICES

11.9.3 KEY STRATEGY

11.9.4 RECENT DEVELOPMENTS

11.9.5 SWOT ANALYSIS

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

The report covers the analysis and forecast of the Weight loss or obesity medications market on global as well as regional level. The study provides historic data of 2016 along with the forecast for the period between 2017 and 2025 based on revenue (USD Mn).

The study provides a detailed view of the weight loss or obesity medications market, by segmenting it based on by drugs type, by distribution channel, by type, by duration of therapy and regional demand. Rising concern in people regarding health problems due to obesity and over-weight, creates a huge demand for weight loss or obesity medicines. Growing incidences of lifestyle related diseases is also a prime factor augmenting the growth of weight loss or obesity medications market during the forecast period.

Regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Middle East and Africa and Latin America. The segmentation also includes by drug type, by distribution channel, by type and duration of therapy.

A comprehensive analysis of the market dynamics that is inclusive of market drivers, restraints, and opportunities is part of the report. Additionally, the report includes potential opportunities in the weight loss or obesity medications market at the global and regional levels. Market dynamics are the factors which impact the market growth, so their analysis helps understand the ongoing trends of the global market. Therefore, the report provides the forecast of the global market for the period from 2017 to 2025, along with offering an inclusive study of the Weight loss or obesity medications market.

The report provides the size of the Weight loss or obesity medications market in 2016 and the forecast for the next nine years up to 2025. The size of the global weight loss or obesity medications market is provided in terms of revenue. Market revenue is defined in USD Mn. The market dynamics prevalent in North America, Europe, Asia Pacific, Middle East and Africa and Latin America has been taken into account in estimating the growth of the global market.

Market estimates for this study have been based on revenue being derived through regional pricing trends. The weight loss or obesity medications market has been analyzed based on expected demand. We have used the bottom-up approach to estimate the global revenue of the weight loss or obesity medications market, split into regions. Based on, drug type, distribution channel, type and duration of therapy we have summed up the individual revenues from all the regions to achieve the global revenue for weight loss or obesity medications. Companies were considered for the market share analysis, based on their innovation and application and revenue generation. In the absence of specific data related to the sales of weight loss or obesity medications several privately held companies, calculated assumptions have been made in view of the company's penetration and regional presence.

The report covers a detailed competitive outlook that includes the market share and company profiles of key players operating in the global market. Key players profiled in the report include Orexigen Therapeutics Inc., Norgine B.V., Amway Enterprises, Merck & Co. Inc., Pfizer Inc., and few likely to be named.

The global weight loss or obesity medications market has been segmented into:

Global Weight Loss or Obesity Medications Market: By Drug Type

Peripherally Acting Drugs

Centrally Acting Drugs

Global Weight Loss or Obesity Medications Market: By Distribution Channel

Hypermarket/ Supermarket

Pharmaceutical Stores

Online Market

Global Weight Loss or Obesity Medications Market: By Type

Over-The-Counter Drugs

Prescription Drugs

Global Weight Loss or Obesity Medications Market: By Duration of Therapy

Short-Term Drugs

Long-Term Drugs

Global Weight Loss or Obesity Medications Market: By Geography

North America

o U.S.

o Canada

o Mexico

Europe

o U.K.

o France

o Germany

o Italy

o Rest of Europe

Asia Pacific

o India

o China

o Japan

o Rest of Asia Pacific

Middle East and Africa

o South Africa

o Rest of Middle East and Africa

Latin America

o Brazil

o Rest of Latin America

READ MORE

Scope

1 INTRODUCTION

1.1 MARKET SEGMENTATION

2 RESEARCH METHODOLOGY

2.1 ECOSYSTEM OF WEIGHT LOSS AND OBESITY MANAGEMENT MARKET

2.2 TOP-DOWN APPROACH

2.3 BOTTOM-UP APPROACH

2.4 ASSUMPTIONS

3 EXECUTIVE SUMMARY

3.1 GLOBAL WEIGHT LOSS AND OBESITY MANAGEMENT MARKET SNAPSHOT

3.2 GLOBAL WEIGHT LOSS AND OBESITY MANAGEMENT MARKET REVENUE, 2017- 2025(USD MN)

4 MARKET OVERVIEW

4.1 INTRODUCTION

4.2 KEY TRENDS ANALYSIS

4.3 PRODUCT DEVELOPMENT AND DIVERSIFICATION ANALYSIS

4.4 PORTERS FIVE FORCE ANALYSIS

4.5 VALUE CHAIN ANALYSIS

4.6 COMPETITIVE LANDSCAPE

4.7 COMPANY MARKET SHARE ANALYSIS

4.8 EXPANSION STRATEGIES ADOPTED BY LEADING PLAYERS

5 GLOBAL WEIGHT LOSS AND OBESITY MANAGEMENT MARKET, BY DRUGS TYPE

5.1 OVERVIEW

5.2 PERIPHERALLY ACTING DRUGS

5.3 CENTRALLY ACTING DRUGS

6 GLOBAL WEIGHT LOSS AND OBESITY MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL

6.1 OVERVIEW

6.2 HYPERMARKET/ SUPERMARKET

6.3 PHARMACEUTICAL STORES

6.4 ONLINE MARKET

7 GLOBAL WEIGHT LOSS AND OBESITY MANAGEMENT MARKET, BY TYPE

7.1 OVERVIEW

7.2 OVER-THE-COUNTER DRUGS

7.3 PRESCRIPTION DRUGS

8 GLOBAL WEIGHT LOSS AND OBESITY MANAGEMENT MARKET, BY DURATION OF THERAPY

8.1 OVERVIEW

8.2 SHORT-TERM DRUGS

8.3 LONG-TERM DRUGS

9 GLOBAL WEIGHT LOSS AND OBESITY MANAGEMENT MARKET, BY GEOGRAPHY

9.1 NORTH AMERICA

9.1.1 MARKET DYNAMICS

9.1.1.1 DRIVERS

9.1.1.2 RESTRAINS

9.1.1.3 OPPORTUNITY

9.1.2 U.S.

9.1.3 CANADA

9.1.4 MEXICO

9.2 EUROPE

9.2.1 MARKET DYNAMICS

9.2.1.1 DRIVERS

9.2.1.2 RESTRAINS

9.2.1.3 OPPORTUNITY

9.2.2 U.K.

9.2.3 FRANCE

9.2.4 GERMANY

9.2.5 SPAIN

9.2.6 REST OF EUROPE

9.3 ASIA PACIFIC

9.3.1 MARKET DYNAMICS

9.3.1.1 DRIVERS

9.3.1.2 RESTRAINS

9.3.1.3 OPPORTUNITY

9.3.2 INDIA

9.3.3 CHINA

9.3.4 JAPAN

9.3.5 REST OF ASIA PACIFIC

9.4 MIDDLE EAST AND AFRICA

9.4.1 MARKET DYNAMICS

9.4.1.1 DRIVERS

9.4.1.2 RESTRAINS

9.4.1.3 OPPORTUNITY

9.4.2 SOUTH AFRICA

9.4.3 REST OF MIDDLE EAST AND AFRICA

9.5 LATIN AMERICA

9.5.1 MARKET DYNAMICS

9.5.1.1 DRIVERS

9.5.1.2 RESTRAINS

9.5.1.3 OPPORTUNITY

9.5.2 BRAZIL

9.5.3 REST OF LATIN AMERICA

10 COMPETATIVE LANDSCAPE

10.1 OVERVIEW

10.2 NEW PRODUCT LAUNCHES

11 GLOBAL WEIGHT LOSS AND OBESITY MANAGEMENT MARKET, BY COMPANY

11.1 INTRODUCTION

11.2 OREXIGEN THERAPEUTICS INC.

11.2.1 BUSINESS OVERVIEW

11.2.2 PRODUCTS & SERVICES

11.2.3 KEY STRATEGY

11.2.4 RECENT DEVELOPMENTS

11.2.5 SWOT ANALYSIS

11.3 AMWAY ENTERPRISES

11.3.1 BUSINESS OVERVIEW

11.3.2 PRODUCTS & SERVICES

11.3.3 KEY STRATEGY

11.3.4 RECENT DEVELOPMENTS

11.3.5 SWOT ANALYSIS

11.4 NORGINE B.V.

11.4.1 BUSINESS OVERVIEW

11.4.2 PRODUCTS & SERVICES

11.4.3 KEY STRATEGY

11.4.4 RECENT DEVELOPMENTS

11.4.5 SWOT ANALYSIS

11.5 MERCK & CO. INC.

11.5.1 BUSINESS OVERVIEW

11.5.2 PRODUCTS & SERVICES

11.5.3 KEY STRATEGY

11.5.4 RECENT DEVELOPMENTS

11.5.5 SWOT ANALYSIS

11.6 PFIZER INC.

11.6.1 BUSINESS OVERVIEW

11.6.2 PRODUCTS & SERVICES

11.6.3 KEY STRATEGY

11.6.4 RECENT DEVELOPMENTS

11.6.5 SWOT ANALYSIS

11.7 ARENA PHARMACEUTICALS INC.

11.7.1 BUSINESS OVERVIEW

11.7.2 PRODUCTS & SERVICES

11.7.3 KEY STRATEGY

11.7.4 RECENT DEVELOPMENTS

11.7.5 SWOT ANALYSIS

11.8 GLAXOSMITHKLINE LIMITED

11.8.1 BUSINESS OVERVIEW

11.8.2 PRODUCTS & SERVICES

11.8.3 KEY STRATEGY

11.8.4 RECENT DEVELOPMENTS

11.8.5 SWOT ANALYSIS

11.9 NOVO NORDISK A/S

11.9.1 BUSINESS OVERVIEW

11.9.2 PRODUCTS & SERVICES

11.9.3 KEY STRATEGY

11.9.4 RECENT DEVELOPMENTS

11.9.5 SWOT ANALYSIS

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS